The paraoxonase (PON1) Gln 192 - Arg polymorphism was examined in a group of sporadic late-onset Alzheimer's disease (AD) patients, in a group of coronary artery disease (CAD) patients, and in normal subjects. The AD sample showed a PON1*R allele frequency significantly lower than the control group (0.225 vs 0.281, p = 0.049). In the CAD patients the *R allele was more frequent than in the controls (0.230 vs. 0.213), though not significantly (p = 0.28). The odds ratios adjusted for age, gender, and APOE polymorphism by logistic regression analysis highlighted that in AD the PON1 RR genotype was significantly protective (OR = 0.41, 95% CI = 0.19 - 0.90; p = 0.025), whereas in CAD it appeared to be a significant risk factor (OR = 5.11, 95% CI = 1.09 - 23.9; p = 0.038) limited to younger patients.
Different pattern of association of paraoxonase Gln192-Arg polymorphism with sporadic late-onset Alzheimer?s disease and coronary artery disease.
2003
Abstract
The paraoxonase (PON1) Gln 192 - Arg polymorphism was examined in a group of sporadic late-onset Alzheimer's disease (AD) patients, in a group of coronary artery disease (CAD) patients, and in normal subjects. The AD sample showed a PON1*R allele frequency significantly lower than the control group (0.225 vs 0.281, p = 0.049). In the CAD patients the *R allele was more frequent than in the controls (0.230 vs. 0.213), though not significantly (p = 0.28). The odds ratios adjusted for age, gender, and APOE polymorphism by logistic regression analysis highlighted that in AD the PON1 RR genotype was significantly protective (OR = 0.41, 95% CI = 0.19 - 0.90; p = 0.025), whereas in CAD it appeared to be a significant risk factor (OR = 5.11, 95% CI = 1.09 - 23.9; p = 0.038) limited to younger patients.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
